Published: 2020-03-26

C reactive protein as a prognostic indicator of severity in patients with acute pancreatitis

Bharath Nayak Ganesh, Srinivas Nanjangud Masana Setty


Background: Acute pancreatitis ranges from a mild illness to a severe disease with high morbidity and mortality. Severity affects the treatment and outcome. The existing scoring systems for assessment of its severity require are time consuming and expensive. This study was an attempt to evaluate the effectiveness of C-reactive protein (CRP) as a prognostic indicator and a marker of severity of acute pancreatitis.

Methods: This was a prospective observational study conducted between among 50 patients diagnosed with acute pancreatitis. The Ranson’s score and CTSI was calculated for these patients. CRP levels were measured 48 hours after the onset of symptoms. They were observed for the development of local and systemic complications, and outcome. These were compared with the CRP values. Pearson coefficient was used to study the correlation between the variables. A p value of less than 0.05 was considered to be statistically significant.

Results: 30 of the 50 patients had no local complications. 14 patients (28%) had peripancreatic collection and 6 (12%) had pancreatic necrosis. 24 of the 50 patients had systemic complications (48%). 25 patients had mild disease and 25 had severe disease as evidenced by the Ranson’s score. These 25 patients with severe disease also had raised CRP (p<0.05). There was no statistically significant correlation between the CTSI and CRP values. 4 patients with CRP values more than 400 succumbed to the illness.

Conclusions: CRP can serve as an inexpensive alternative to the conventional severity assessment methods for the prediction of severity and outcome of patients with acute pancreatitis.


Acute pancreatitis, CRP, Prognostic indicator, Severity of disease

Full Text:



Zinner MJ, Ashley SW. Maingot’s abdominal operations.13th edition. McGraw-Hill’s. 2006:3069.

Sabiston textbook of surgery: the biological basis of modern surgical practice. Philadelphia: Elsevier Saunders; 2017:1524.

Wang GJ, Ga CF, Wei D, Wang C, Ding SQ. Acute pancreatitis: etiology and common pathogenesis. World J Gastroenterol. 2009;15(12):1427-30.

Shah AP, Mourad MM, Bramhall SR. Acute pancreatitis: current perspectives on diagnosis and management. J Inflamm Res. 2018;11:77-85.

Matull WR, Pereira SP, O’Donohue JW. Biochemical markers of acute pancreatitis. J Clin Pathol. 2006;59(4):340-4.

UK working party on acute pancreatitis. UK guidelines for the management of acute pancreatitis. Gut. 2005;54 (3):1-9.

Toouli J, Smith BM, Bassi C. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol. 2002;17:515-39.

Cho JH, Kim TN, Chung HH, Kim KH. Comparison of scoring systems in predicting the severity of acute pancreatitis. World J Gastroenterol. 2015;21(8):2387-94.

Nehring SM, Patel BC. C reactive protein (CRP). In: stat pearls. Treasure Island (FL): Stat Pearls Available at: https:// www. ncbi. nlm. nih. gov/ books/ NBK441843/?report=classic. Accessed on 12 November 2019.

Botoi G, Andercou A. Interleukin 17-prognostic marker of severe acute pancreatitis. Chirurgia. 2009;104(4):431-8.

Khanna AK, Meher S, Prakash S. Comparison of ranson, glasgow, moss, sirs, bisap, apache-ii, ctsi scores, il-6, crp, and procalcitonin in predicting severity, organ failure, pancreatic necrosis, and mortality in acute pancreatitis. HPB Surg. 2013;2013:10.

Tenner S, Baillie J, Dewitt J, Swaroop VS. American college of gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400-15.

Deherkar J, Pandey J, Deshmukh A, Shahaji. C-reactive protein levels in acute pancreatitis and its clinical significance. Int Surg J. 2019;6:3328.

Pezzilli R, Billi P, Miniero R, Fiocchi M, Cappelletti O, Maria A, et al. Serum interleukin-6, interleukin-8, and β2 microglobulin in early assessment of severity of acute pancreatitis: comparison with serum C-reactive protein. Dig Dis Sci. 1995;40(11):2341-8.

Joshi M, Joshi AA, Gokhale A, Manay P, Gadhire M, Singh MB. C-reactive protein levels in acute pancreatitis and its prognostic significance. J Evol Med Dental Sci. 2013;2(48):9404-9.

Trivikraman R, Ramesan C, Joji M. Validity of bedside index of severity in acute pancreatitis score in comparison with C reactive protein in assessing the severity of acute pancreatitis. Int J Res Med Sci. 2016;4:5248-51.

Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med. 2001;164:162-70.

Stirling AD, Moran NR, Kelly ME, Ridgway PF, Conlon KC. The predictive value of C-reactive protein (CRP) in acute pancreatitis is interval change in CRP an additional indicator of severity? HPB Oxford. 2017;19:874-80.

Wang Y, Li L. Predicative values of c-reactive protein for the therapeutic effects of ulinastatin combined with somatostatin in severe acute pancreatitis and for the severity of gastrointestinal failure. Experimen Therap Med. 2018;6:3165-71.